Ignite Creation Date:
2024-05-06 @ 1:20 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03991403
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-04-03
First Post:
2019-06-05
Brief Title:
Study of Atezolizumab Combination Carboplatin Paclitaxel Bevacizumab in EGRF Mutation or ALK Translocation NSCLC
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-11
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-05
First Submit QC Date:
June 18 2019
Study First Post Date:
2019-06-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-29
Last Update Post Date:
2023-04-03
Last Update Post Date Type:
ACTUAL